#torrent-pharma
भारत , ब्राजील और अमेरिका कारोबार से Torrent Pharma को फायदा , ब्रोकरेज ने दिया ₹5 , 230 तक का टारगेट - brokerages bullish on torrent pharma after strong q4 semaglutide and jb deal drive growth hopes
After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch
Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health
Torrent Pharma Q4 profit drops 26% on JB Pharma acquisition costs, severance compensation
Torrent Pharma reports a 26% net profit decline despite 42% revenue growth, while planning a ₹5,000 crore QIP.